Transforming the Pediatric Experience: The Story of Child Life

Pediatric Annals
|September 12, 2017
PubMed

Insights

Child life programming offers vital support for children facing stressful events, reducing anxiety and promoting well-being. These specialists provide crucial coping strategies and emotional support in healthcare and other challenging settings.

Area of Science:

  • Pediatric healthcare
  • Child psychology
  • Psychosocial support

Background:

  • Child life programming has become a standard of care over the past century.
  • Professionals now assist children in various settings, including clinics, dental offices, and legal environments.
  • Child life specialists are recognized by the American Academy of Pediatrics for their role in supporting children's well-being.

Purpose of the Study:

  • To highlight the evolution and importance of child life programming.
  • To emphasize the role of child life specialists in mitigating the adverse effects of stressful experiences on children.
  • To advocate for the inclusion of child life programming as a standard of care in pediatric settings.

Main Methods:

  • The study reviews the historical development and current practices of child life programming.
  • It emphasizes the expertise of child life specialists in child development and therapeutic interventions.
  • The abstract outlines the range of services provided, including therapeutic play, procedural education, and emotional support.

Main Results:

  • Child life programming effectively reduces anxiety and fear associated with emotional and physical pain in children.
  • Specialists utilize developmentally appropriate language and therapeutic play to promote normalcy and coping.
  • Services extend to procedural education, emotional support, pain management, and grief/bereavement support.

Conclusions:

  • Child life programming is integral to addressing psychosocial concerns across the healthcare continuum.
  • These programs play a critical role in minimizing the negative impacts of stressful environments on children.
  • Child life programming should be a standard component of quality care in all general pediatric provider settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371
Life Histories01:29

Life Histories

Overview
23.0K